Global marketing group Cello has announced an increase in revenue of 2.8 per cent for 2012, reaching £63.3m, while group profit has increased by 7.2 per cent to £31.7m as it saw continued growth for its health marketing business.
The group has made a pre-tax profit for 2012 of £3m, an increase of 2.2 per cent on 2011.
The group’s gross profit was £16.4m in Cello Health, an increase of £3.2m on the previous year, however Cello Consumer saw a decline in gross profit by £1.1m to £15.2m for 2012. Cello Health recorded an operating profit of £4.1m and Cello Consumer of £0.1m.
Cello Health saw an increase in the overall proportion of international revenue to 37 per cent, having expanded into New York, while planning to open in Philadelphia and Hong Kong later this year, while over 65 per cent continued to come from the UK.
Mark Scott, chief executive, commented: "Cello continues to make strong headway implementing its stated strategy. Cello Health is becoming established as a leading business in the global pharmaceutical market. The Group's international revenues are growing, the Group's value added advisory revenues are growing and our web capabilities are cutting edge. This positions the Group well for future expansion in line with the strategy. The Group believes that management expectations for headline operating profits will be met."